Type III juvenile pityriasis rubra pilaris: A successful treatment with infliximab [12]

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 1, 2008, Pages 117-118

  Ruzzetti, M ^a   Saraceno, Rosita ^a   Carboni, I ^a   Papoutsaki, M ^a   Chimenti, S ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CYCLOSPORIN; EMOLLIENT AGENT; INFLIXIMAB; KERATOLYTIC AGENT; METHOTREXATE; RETINOID;

ABSENCE OF SIDE EFFECTS; ACANTHOSIS; ADULT; CASE REPORT; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG TOLERABILITY; DRY SKIN; ERYTHEMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; INFLAMMATORY INFILTRATE; LETTER; NAIL DYSTROPHY; PALMOPLANTAR KERATODERMA; PAPULE; PARAKERATOSIS; PITYRIASIS RUBRA PILARIS; PRIORITY JOURNAL; PRURITUS; PSORIASIS; REPEATED DRUG DOSE; SKIN EXFOLIATION; SKIN FISSURE;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; PITYRIASIS RUBRA PILARIS; SKIN; TREATMENT OUTCOME;

EID: 37749023517     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02282.x     Document Type: Letter

References (10)

1. Griffiths WA. Pityriasis rubra pilaris. Clin Exp Dermatol 1980; 5: 105-112.
2. Drosou A, Kirsner RS, Welsh E, Sullivan TP, Kerdel FA. Use of infliximab, an anti-tumor necrosis alpha antibody, for inflammatory dermatoses. J Cutan Med Surg 2003; 7: 382-386.
3. Liao WC, Mutasim DF. Infliximab for the treatment of adult-onset pityriasis rubra pilaris. Arch Dermatol 2005; 141: 423-425.
4. Manoharan S, White S, Gumparthy K. Successful treatment of type I adult-onset pityriasis rubra pilaris with infliximab. Australas J Dermatol 2006; 47: 124-129.
5. Alexis AF, Strober BE. Off-label dermatologic uses of anti-TNFα therapies. J Cutan Med Surg 2005; 9: 296-302.
6. Gupta AK, Skinner AR. A review of the use of infliximab to manage cutaneous dermatoses. J Cutan Med Surg 2004; 8: 77-89.
7. Hughes AP, Jackson JM, Callen JP. Clinical features and treatment of peristomal pyoderma gangrenosum. JAMA 2000; 284: 1546-1548.
8. Botros N, Pickover L, Das KM. Image of the Month. Pyoderma gangrenosum caused by ulcerative colitis. Gastroenterology 2000; 118: 809.
9. Albert MR, Mackool BT. Pityriasis rubra pilaris. Int J Dermatol 1999; 38: 1-11.
10. Bianchi L, Bergamin A, de Felice C, Capriotti E, Chimenti S. Remission and time of resolution of nail psoriasis during infliximab therapy. J Am Acad Dermatol 2005; 52: 736-737.